| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.04 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |